An interventional study of Phrenic nerve stimulation in Neurosurgery, Phrenic Nerve Stimulation and Postoperative Delirium, sponsored by Beijing Sanbo Brain Hospital. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-04.
Sponsored by Beijing Sanbo Brain Hospital · Not applicable, Interventional, and Prevention
This prospective, single-center, randomized controlled clinical trial aims to investigate the impact of intraoperative phrenic nerve stimulation (i.e., diaphragmatic neuromodulation) on postoperative complications in neurosurgical patients. The primary objective is to assess the effect on postoperative brain injury, including the development of delirium and changes in biomarkers. Additionally, the incidence of postoperative pulmonary complications will be investigated.
【Background】Postoperative complications, such as delirium and pulmonary complications, commonly occur in patients undergoing craniotomy. In preclinical studies, phrenic nerve stimulation (i.e., diaphragmatic neuromodulation) has been reported to effectively mitigate brain injury and pulmonary complications. However, its intraoperative administration and its impact on postoperative complications in this population are largely unknown.
【Method】In this prospective, single-center, randomized controlled clinical trial, patients receiving elective craniotomy will be screened. Eligible patients will be randomly divided into three groups: 1) Control group (without any interventions); 2) Intraoperative phrenic nerve stimulation (PNS) without total neuromuscular blockade (Train-of-Four (TOF) = 0); 3) Intraoperative PNS with partial neuromuscular blockade (TOF in the range of 1-2). Diaphragm ultrasound will be performed to assess diaphragm function before surgery and at 24 hours and 48 hours after surgery, respectively. Postoperative delirium will be assessed daily using the 3D-CAM and CAM-ICU within 3 days. Plasma biomarkers of brain injury will also be tested at baseline, 24 hours, and 48 hours after surgery. Pulmonary complications will be diagnosed by three independent clinicians based on laboratory tests, imaging, and clinical signs.
【Aims and Hypothesis】The primary aims are to investigate the impact of intraoperative diaphragmatic neuromodulation on brain injury, including the occurrence of delirium and changes in biomarkers. The secondary aims are the incidence of postoperative pulmonary complications and other clinical outcomes. We hypothesize that intraoperative diaphragmatic neuromodulation could reduce brain injury induced by craniotomy, as well as the incidence of postoperative delirium and pulmonary complications.
763 studies on the registry are indexed under Emergence Delirium; 241 are open to participants now.
This study's enrollment of 120 is close to the median of 120 across 475 interventional studies indexed under Emergence Delirium.
Browse Emergence Delirium studies →Beijing Sanbo Brain Hospital is the lead sponsor of 17 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
No intervention will be performed; all protocols during surgery will follow the clinical routine.
Patients in this group will receive PNS during surgery, with the train-of-four (TOF) maintained at a level of 0. Additionally, to ensure complete blockade of the neuromuscular system, the Post-Tetanic Count (PTC) will be monitored and maintained at less than or equal to 3 simultaneously.
Other: Phrenic nerve stimulation
Patients in this group will receive PNS during surgery, and the TOF will be maintained at levels 1-2. In this group, the neuromuscular junction will not be fully blocked.
Other: Phrenic nerve stimulation
A commercial phrenic nerve stimulation equipment will be used during surgery. Phrenic nerve stimulation intensity will be determined before surgery, ensuring significant diaphragm contraction under stimulation. The use of an electric knife will be avoided during surgery. Tidal volume, airway pressure, and vital signs will be monitored continuously.
Incidence of delirium
The incidence of delirium is documented using validated delirium scores, determined by either a positive result from the 3-minute diagnostic interview for the Confusion Assessment Method (3D-CAM) scoring sheet, the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), or both
Time frame: Within 3 days after surgery
Postoperative pulmonary complications
Postoperative pulmonary complications may include respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, bronchospasm, acute respiratory distress syndrome, aspiration pneumonia, pulmonary embolism, pulmonary edema, and aggravation of existing lung diseases.
Time frame: Within 7 days after surgery
Post operative diaphragm dysfunction
The patient is placed in a supine position, with a high-frequency linear array probe positioned between the right axillary midline and the 8th to 10th ribs. The probe is rotated to align parallel to the intercostal space. When two parallel high-echo lines appear, the diaphragm is identified between them. The sampling line is placed in the diaphragm movement area, and once the image stabilizes, it is converted to an M-mode ultrasound. The thickness of the inspiratory and expiratory diaphragmatic muscles is measured separately, and the maximum value is obtained by repeating the measurements three times. Diaphragm dysfunction is defined as a fraction of diaphragm thickening less than 20%.
Time frame: Before the surgery and within 24 hours and 48 hours after surgery.
Length of stay in Intensive Care Unit (ICU)
The time between the patient's admission to the ICU and the patient's discharge from the ICU is referred to as the length of stay in the ICU.
Time frame: The time from ICU admission to transfer to the ward or death, whichever occurred first, was assessed for up to 180 days.
Length of hospital stay
The time between the patient's admission to the hospital and the patient's discharge from the hospital is referred to as the length of stay in the hospital.
Time frame: The period from hospital admission to discharge or death, whichever occurred first, was assessed for up to 180 days.
White blood cell
Collect preoperative and postoperative blood routine and biochemical information from patients, specifically focusing on white blood cell counts before and after surgery.
Time frame: Before the surgery and within 24 hours and 48 hours after surgery.
S100 calcium-binding protein B (S-100B)
Evaluation of serum S-100B protein levels in patients at baseline, immediate postoperative state, and 48 hours after surgery.
Time frame: Before the surgery and within 24 hours and 48 hours after surgery.
Glial Fibrillary acidic protein (GFAP)
Evaluation of serum GFAP levels in patients at baseline, immediate postoperative state, and 48 hours after surgery.
Time frame: Before the surgery and within 24 hours and 48 hours after surgery.
Brain-derived neurotrophic factor (BDNF)
Evaluation of serum BDNF levels in patients at baseline, immediate postoperative state, and 48 hours after surgery.
Time frame: Before the surgery and within 24 hours and 48 hours after surgery.
Neuron-specific enolase (NSE)
Evaluation of serum NSE levels in patients at baseline, immediate postoperative state, and 48 hours after surgery.
Time frame: Before the surgery and within 24 hours and 48 hours after surgery.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beijing Sanbo Brain Hospital